AU2003278814A1 - Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof - Google Patents
Ligands for the peroxisome proliferator-activated receptor, and methods of use thereofInfo
- Publication number
- AU2003278814A1 AU2003278814A1 AU2003278814A AU2003278814A AU2003278814A1 AU 2003278814 A1 AU2003278814 A1 AU 2003278814A1 AU 2003278814 A AU2003278814 A AU 2003278814A AU 2003278814 A AU2003278814 A AU 2003278814A AU 2003278814 A1 AU2003278814 A1 AU 2003278814A1
- Authority
- AU
- Australia
- Prior art keywords
- ligands
- methods
- activated receptor
- peroxisome proliferator
- proliferator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 title 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41067702P | 2002-09-13 | 2002-09-13 | |
US60/410,677 | 2002-09-13 | ||
PCT/US2003/028931 WO2004024939A2 (en) | 2002-09-13 | 2003-09-12 | Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003278814A1 true AU2003278814A1 (en) | 2004-04-30 |
AU2003278814A8 AU2003278814A8 (en) | 2004-04-30 |
Family
ID=31994180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003278814A Abandoned AU2003278814A1 (en) | 2002-09-13 | 2003-09-12 | Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003278814A1 (en) |
WO (1) | WO2004024939A2 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4638423B2 (en) | 2003-06-20 | 2011-02-23 | ガルデルマ・リサーチ・アンド・デヴェロップメント | Novel compounds that modulate PPARγ type receptors and their use in cosmetic or pharmaceutical compositions |
GB0403864D0 (en) | 2004-02-20 | 2004-03-24 | Ucl Ventures | Modulator |
EP1745027A4 (en) * | 2004-05-14 | 2009-06-03 | Irm Llc | Compounds and compositions as ppar modulators |
AU2005297800B2 (en) * | 2004-10-29 | 2011-02-03 | Zeria Pharmaceutical Co., Ltd. | Carbazole derivative, solvate thereof, or pharmaceutically acceptable salt thereof |
KR20070085997A (en) * | 2004-11-19 | 2007-08-27 | 갈데르마 리써어치 앤드 디벨로프먼트 | Compounds modulating PPARγ type receptors, and their use in cosmetic or pharmaceutical compositions |
FR2878247B1 (en) | 2004-11-19 | 2008-10-03 | Galderma Res & Dev | NOVEL MODULATING COMPOUNDS OF PPARY RECEPTORS AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS |
TW200811164A (en) * | 2006-05-12 | 2008-03-01 | Jerini Ag | New heterocyclic compounds for the inhibition of integrins and use thereof |
AU2007307597A1 (en) | 2006-10-12 | 2008-04-17 | Institute Of Medicinal Molecular Design. Inc. | Carboxylic acid derivatives |
AU2009234899A1 (en) * | 2008-04-11 | 2009-10-15 | Institute Of Medicinal Molecular Design, Inc. | PAI-1 inhibitor |
US8633245B2 (en) | 2008-04-11 | 2014-01-21 | Institute Of Medicinal Molecular Design, Inc. | PAI-1 inhibitor |
MX2011004006A (en) | 2008-11-19 | 2011-05-19 | Pola Chem Ind Inc | Anti-wrinkle agents. |
WO2010091142A1 (en) * | 2009-02-04 | 2010-08-12 | President And Fellows Of Harvard College | Compositions and methods for labeling and imaging phospholipids |
KR20220162116A (en) * | 2021-05-25 | 2022-12-07 | 주식회사 자이메디 | Novel compounds inhibiting the binding between AIMP2-DX2 and KRAS and their uses |
-
2003
- 2003-09-12 WO PCT/US2003/028931 patent/WO2004024939A2/en not_active Application Discontinuation
- 2003-09-12 AU AU2003278814A patent/AU2003278814A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004024939A3 (en) | 2004-10-14 |
WO2004024939A2 (en) | 2004-03-25 |
AU2003278814A8 (en) | 2004-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002335231A1 (en) | Activator for peroxisome proliferator-activated receptor delta | |
AU2003299791A1 (en) | Substituted 3,5-dihydro-4h-imidazol-4-ones for the treatment of obesity | |
AU2002323776A1 (en) | Activator for peroxisome proliferator-responsive receptor Delta | |
AU2003233010A1 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
IL160964A0 (en) | Peroxisome proliferator activated receptor ligand and process for producing the same | |
AU2003267728A1 (en) | Cannabinoid receptor ligands and uses thereof | |
AU2003279442A1 (en) | 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes | |
AU2003231352A1 (en) | Biocidal formulation and methods for the preparation thereof | |
IL161578A0 (en) | Peroxisome proliferator activated receptor agonists | |
AU2003299648A1 (en) | Substituted 4-phenyl-(1,3)-dioxanes | |
AU2003278814A1 (en) | Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof | |
AU2003292508A1 (en) | N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands | |
AU2003260984A1 (en) | S-(-)-amlodipine nicotinate and process for the preparation thereof | |
AU2002347985A1 (en) | Peroxisome proliferator activated receptor alpha agonists | |
SI1532141T1 (en) | 2-PYRROLIDIN-2-YL- ?á1,3,4?å-OXADIAZOLE DERIVATIVES AND THE USE OF THE SAME AS ANTIDEPRESSANTS | |
AU2003289176A1 (en) | 1,3-benzothiazinone derivatives, process for producing the same and use thereof | |
TWI348382B (en) | N-acetylglucosamine derivatives, and the use thereof | |
AU2002325164A1 (en) | Receptor, the use thereof, and mouse antibodies | |
AU2003216546A1 (en) | Ultrasonic microkeratome | |
AU2003277665A1 (en) | Peroxisome proliferator-activated recetor ligand | |
AU2003300262A1 (en) | Phthalimidylazo dyes, processes for the preparation thereof and the use thereof | |
AU2003296545A1 (en) | Use of a trpm8-activating substance for the treatment of tumours | |
AU2003281698A1 (en) | 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof | |
AU2002335304A1 (en) | The use of berberine as insulin sensitizer | |
AU2003261927A1 (en) | Peroxisome proliferator-activated receptor controllers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |